Puma Biotechnology CEO to present at investor conferences beginning Jan 10, 2022

PUMA BIOTECHNOLOGY, INC.

CEO Alan Auerbach will present at conferences and other forums starting January 10, 2022.
Presentation slides attached as Exhibit 99.1 contain the information to be disclosed.
No specific financial or operational details from the slides are available in this filing text.

item 7.01 item 9.01

PUMA BIOTECHNOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001437749-22-000622

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.